XML 63 R34.htm IDEA: XBRL DOCUMENT v3.22.0.1
Goodwill and Other Intangible Assets (Tables)
9 Months Ended
Jan. 28, 2022
Goodwill and Intangible Assets Disclosure [Abstract]  
Changes in the Carrying Amount of Goodwill
The following table presents the changes in the carrying amount of goodwill by segment:
(in millions)CardiovascularMedical SurgicalNeuroscienceDiabetesTotal
April 30, 2021$7,209 $21,195 $11,300 $2,257 $41,961 
Goodwill as a result of acquisitions55 — 26 — 80 
Purchase accounting adjustments26 (2)30 
Currency translation and other(58)(575)(92)(1)(726)
January 28, 2022$7,232 $20,623 $11,237 $2,254 $41,346 
Gross Carrying Amount and Accumulated Amortization of Definite-Lived Intangible Assets
The following table presents the gross carrying amount and accumulated amortization of intangible assets:
January 28, 2022April 30, 2021
(in millions)Gross Carrying AmountAccumulated AmortizationGross Carrying AmountAccumulated Amortization
Definite-lived:
Customer-related$16,990 $(6,775)$17,036 $(6,058)
Purchased technology and patents10,834 (5,506)11,286 (5,156)
Trademarks and tradenames474 (262)475 (251)
Other78 (66)82 (68)
Total$28,376 $(12,609)$28,879 $(11,533)
Indefinite-lived:
IPR&D$311 $— $394 $— 
Gross Carrying Amount of Indefinite-Lived Intangible Assets
The following table presents the gross carrying amount and accumulated amortization of intangible assets:
January 28, 2022April 30, 2021
(in millions)Gross Carrying AmountAccumulated AmortizationGross Carrying AmountAccumulated Amortization
Definite-lived:
Customer-related$16,990 $(6,775)$17,036 $(6,058)
Purchased technology and patents10,834 (5,506)11,286 (5,156)
Trademarks and tradenames474 (262)475 (251)
Other78 (66)82 (68)
Total$28,376 $(12,609)$28,879 $(11,533)
Indefinite-lived:
IPR&D$311 $— $394 $— 
Estimated Future Aggregate Amortization Expense, Definite-Lived Intangible Assets Estimated aggregate amortization expense by fiscal year based on the carrying value of definite-lived intangible assets at January 28, 2022, excluding any possible future amortization associated with acquired IPR&D which has not yet met technological feasibility, is as follows:
(in millions)Amortization Expense
Remaining 2022$430 
20231,663 
20241,629 
20251,606 
20261,592 
20271,568